DEA schedule
Is Zubsolv a controlled substance?
Zubsolv contains buprenorphine and naloxone. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Zubsolv (buprenorphine and naloxone) is a Schedule III controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Buprenorphine (Schedule III).
Run it in Rivvi
Which 2027 plans near you dropped or restricted Zubsolv?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 12 prescription listings from 2 labelers, all Schedule III |
| DEA controlled substances list | Buprenorphine: Schedule III |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Buprenorphine | 9064 | III | Yes | Buprenex; Temgesic; Subutex; Suboxone | Listed by name |
Zubsolv NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 54123-907 | Zubsolv | tablet, orally disintegrating | .7 mg/1; .18 mg/1 | Orexo US, Inc. | CIII |
| 82111-201 | Zubsolv | tablet, orally disintegrating | .7 mg/1; .18 mg/1 | Edenbridge Pharmaceuticals LLC. | CIII |
| 54123-914 | Zubsolv | tablet, orally disintegrating | 1.4 mg/1; .36 mg/1 | Orexo US, Inc. | CIII |
| 82111-202 | Zubsolv | tablet, orally disintegrating | 1.4 mg/1; .36 mg/1 | Edenbridge Pharmaceuticals LLC. | CIII |
| 54123-114 | Zubsolv | tablet, orally disintegrating | 11.4 mg/1; 2.9 mg/1 | Orexo US, Inc. | CIII |
| 82111-206 | Zubsolv | tablet, orally disintegrating | 11.4 mg/1; 2.9 mg/1 | Edenbridge Pharmaceuticals LLC. | CIII |
| 54123-929 | Zubsolv | tablet, orally disintegrating | 2.9 mg/1; .71 mg/1 | Orexo US, Inc. | CIII |
| 82111-203 | Zubsolv | tablet, orally disintegrating | 2.9 mg/1; .71 mg/1 | Edenbridge Pharmaceuticals LLC. | CIII |
| 54123-957 | Zubsolv | tablet, orally disintegrating | 5.7 mg/1; 1.4 mg/1 | Orexo US, Inc. | CIII |
| 82111-204 | Zubsolv | tablet, orally disintegrating | 5.7 mg/1; 1.4 mg/1 | Edenbridge Pharmaceuticals LLC. | CIII |
| 54123-986 | Zubsolv | tablet, orally disintegrating | 8.6 mg/1; 2.1 mg/1 | Orexo US, Inc. | CIII |
| 82111-205 | Zubsolv | tablet, orally disintegrating | 8.6 mg/1; 2.1 mg/1 | Edenbridge Pharmaceuticals LLC. | CIII |
Questions
Is Zubsolv a controlled substance?
Yes. Zubsolv (buprenorphine and naloxone) is a Schedule III controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Buprenorphine (Schedule III).
Is Zubsolv a narcotic?
Yes. The DEA list marks buprenorphine and naloxone as a narcotic (NARC = Y) and places it in Schedule III. Its FDA established pharmacologic class is Opioid Antagonist and Partial Opioid Agonist.
What schedule is Zubsolv?
Zubsolv is Schedule III in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Zubsolv
- What is Zubsolv used for?FDA label uses
- Generic for ZubsolvFDA Orange Book
- What is Buprenorphine and Naloxone used for?FDA label uses
- Is Buprenorphine and Naloxone a controlled substance?Schedule III
- Generic for SuboxoneFDA Orange Book
- Opioid Antagonists listFDA drug class
- Partial Opioid Agonists listFDA drug class
- Zubsolv Medicare Part D coverageBy plan and state
- NDC 54123-114Zubsolv NDC record
- NDC 54123-907Zubsolv NDC record
- NDC 54123-914Zubsolv NDC record
- Schedule III drugs listDEA schedule